This page contains a Flash digital edition of a book.
ARTICLE | THE MALE FACE | References


1. Springer IN, Zernial O, Nölke F et al. Gender and nasal shape: measures for rhinoplasty. Plast Reconstr Surg 2008; 121(2): 629–37


2. Peterson JD, Goldman MP. Laser, light, and energy devices for cellulite and lipodystrophy. Clin Plast Surg 2011; 38(3): 463–74


3. Walrath DE, Turner P, Bruzek J. Reliability test of the visual assessment of cranial traits for sex determination. Am J Phys Anthropol 2004; 125(2): 132–7


4. Foos PW, Clark MC. Adult age and gender differences in perception of facial attractiveness: beauty is in the eye of the older beholder. J Genet Psychol 2011; 172(2): 162–75


5. Thorndike EL. A constant error on psychological rating. J Appl Psychol 1920; 4: 25–9


6. Mommaerts MY, Moerenhout BA. Idea proportions in full face front view, contemporary versus antique. J Craniomaxillofac Surg 2011; 39(2): 107–10


7. Windhager S, Schaefer K, Fink B. Geometric morphometrics of male facial shape in relation to physical strength and perceived attractiveness, dominance, and masculinity. Am J Human Biol 2011; 23(6): 805–14


8. Fink B, Neave N, Seydel H. Male facial appearance signals physical strength to women. Am J Human Biol 2007; 19(1): 82–7


9. Pivonkova V, Rubesova A, Lindova J, Havlicek J. Sexual dimorphism and personality attributions of male faces. Arch Sex Behav 2011; 40(6): 1137–43


10. Rennels JL, Bronstad PM, Langlois JH. Are attractive men’s faces masculine or feminine? The importance of type of facial stimuli. J Exp Psychol Hum Percept Perform 2008; 34(4): 884–93


11. Sharabi SE, Hatef DA, Hollier LH Jr. Facial attractiveness: is the whole more than the sum of its parts? Aesthet Surg J 2010; 30(2): 154–60


12. Hexsel C, Hexsel D, Porto MD, Schilling J, Siega C. Botulinum toxin type A for aging face and aesthetic use. Dermatol Ther 2011; 24(1): 54–61


13. Carruthers A, Carruthers J. Prospective, double-blind, randomized, parallel group, dose-ranging study of botulinum toxin type A in men with glabella rhytids. Dermatol Surg 2005; 31(10): 1297–303


14. Flynn TC. Botox in men. Dermatol Ther 2007; 20(6): 407–10


15. Carruthers J, Carruthers A. A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivate compared with the derivate and BTX-A. Dermatol Surg 2003; 29(8): 802–9


16. Goldman A, Wollina U. Facial rejuvenation for middle-aged women: a combined approach with minimallay invasive procedures. Clin Interv Aging 2010; 5: 293–9


17. Wollina U, Konrad H. Managing adverse events associated with botulinum toxin type A: a focus on cosmetic procedures. Am J Clin Dermatol 2005; 6(3): 141–50


18. Ranu H, Thng S, Goh BK, Burger A, Goh CL. Periorbital Hyperpigmentation in Asians: An Epidemiologic Study and a Proposed Classification. Dermatol Surg 2012; [Epub ahead of print]


19. Moody MN, Landau JM, Goldberg LH, Friedman PM. Fractionated 1550-nm erbium-doped fiber laser for the treatment of periorbital hyperpigmentation. Dermatol Surg 2012; 38(1): 139–42


20. Eberlin S, Del Carmen Velazquez Pereda M, de Campos Dieamant G, Nogueira C, Werka RM, de Souza Queiroz ML. Effects of a Brazilian herbal compound as a cosmetic eyecare for periorbital hyperchromia (‘dark circles’). J Cosmet Dermatol 2009; 8(2): 127–35


21. Wollina U. Treatment of facial skin laxity by a new monopolar radiofrequency device. J Cutan Aesthet Surg 2011; 4(1): 7–11


Dermatol Venereol 2012; 26(2): 186–93


22. Bonan P, Campolmi P, Cannarozzo G, Bruscino N, Bassi A, Betti S, Lotti T. Eyelid skin tightening: a novel ‘Niche’ for fractional CO2


rejuvenation. J Eur Acad


23. Choi YJ, Lee JY, Ahn JY, Kim MN, Park MY. The safety and efficacy of a combined diode laser and bipolar radiofrequency compared with combined infrared light and bipolar radiofrequency for skin rejuvenation. Indian J Dermatol Venereol Leprol 2012; 78(2): 146–52


24. Graivier MH, Bass LS, Busso M, Jasin ME, Narins RS, Tzikas TL. Calcium hydroxylapatite (Radiesse) for correction of the mid- and lower face: consensus recommendations. Plast Reconstr Surg 2007; 120(6 Suppl): 55S–66S


25. Funt DK. Avoiding malar edema during midface/ cheek augmentation with dermal fillers. J Clin Aesthet Dermatol 2011; 4(12): 32–6


26. Santoro S, Russo L, Argenzio V, Borzacchiello A. 26 ❚


Rheological properties of cross-linked hyaluronic acid dermal fillers. J Appl Biomater Biomech 2011; 9(2): 127–36


27. Monheit GD, Prather CL. Hyaluronic acid fillers for the male patient. Dermatol Ther 2007; 20(6): 394–406


28. Wollina U, Goldman A, Berger U, Abdel-Naser MB. Esthetic and cosmetic dermatology. Dermatol Ther 2008; 21(2): 118–30


29. Wollina U, Goldman A. Minimally invasive aesthetic procedures in young adults. Clin Cosmet Investig Dermatol 2011; 4: 19–26


30. Bartus CL, Sattler G, Hanke CW. The tower technique: a novel technique for the injection of hyaluronic acid fillers. J Drugs Dermatol 2011; 10(11): 1277–80


31. Goldie K. New techniques of 3D vectoring using atraumatic cannulae. Prime 2011; 1(4): 24–34


32. Skeie L, Bugge H, Negaard A, Bergersen BM. Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study. HIV Med 2010; 11(3): 170–7


33. Borelli C, Kunte C, Weisenseel P, Thoma-Greber E, Korting HC, Konz B. Deep subcutaneous application of poly-L-lactic acid as a filler for facial lipoatrophy in HIV-infected patients. Skin Pharmacol Physiol 2005; 18(6): 273–8


34. Redbord KP, Busso M, Hanke CW. Soft-tissue augmentation with hyaluronic acid and calcium hydroxyl apatite fillers. Dermatol Ther 2011; 24(1): 71–81


35. Goldman A, Wollina U, de Mundstock EC. Evaluation of tissue tightening by the subdermal Nd: YAG laser-assisted liposuction versus liposuction alone. J Cutan Aesthet Surg 2011; 4(2): 122–8


36. Goldman A, Wollina U. Elevation of the corner of the mouth using botulinum toxin type a. J Cutan Aesthet Surg 2010; 3(3): 145–50


37. Goldman A, Schavelzon DE, Blugerman GS. Laser lipolysis: liposuction using Nd-YAG laser. Rev Soc Bras Cir Plast 2002; 17: 17–26


38. Goldman A. Submental Nd:YAG laser-assisted liposuction. Lasers Surg Med 2006; 38(3): 181–4


39. Alexiades-Armenakas M. Combination laser- assisted liposuction and minimally invasive skin tightening with temperature feedback for treatment of the submentum and neck. Dermatol Surg 2012; [Epub ahead of print]


40. Oresajo C, Yatskayer M, Hansenne I. Clinical tolerance and efficacy of capryloyl salicylic acid peel compared to a glycolic acid peel in subjects with fine lines/wrinkles and hyperpigmented skin. J Cosmet Dermatol 2008; 7(4): 259–62


41. Merinville E, Byrne AJ, Rawlings AV, Muggleton AJ, Laloeuf AC. Three clinical studies showing the anti-aging benefits of sodium salicylate in human skin. J Cosmet Dermatol 2010; 9(3): 174–84


42. Levesque A, Hamzavi I, Seite S, Rougier A, Bissonnette R. Randomized trial comparing a chemical peel containing a lipophilic hydroxy acid derivative of salicylic acid with a salicylic acid peel in subjects with comedonal acne. J Cosmet Dermatol 2011; 10(3): 174–8


43. Dréno B, Fischer TC, Perosino E et al. Expert opinion: efficacy of superficial chemical peels in active acne management--what can we learn from the literature today? Evidence-based recommendations. J Eur Acad Dermatol Venereol 2011; 25(6): 695–704


44. Zhou Y, Banga AK. Enhanced delivery of cosmeceuticals by microdermabrasion. J Cosmet Dermatol 2011; 10(3): 179–84


45. Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 2004; 34(5): 426–38


46. Paasch U, Haedersdal M. Laser systems for ablative fractional resurfacing. Expert Rev Med Devices 2011; 8(1): 67–83


47. Grunewald S, Bodendorf MO, Elsner J et al. Ablative fractional laser treatment – practical recommendations. Kosmet Med/Cosmet Med 2012; 33: 8–14


Figure 7 48-year-old with acne scars, porous skin, and flaccidity. (A) and (C) before procedure. (B) and (D) result after two sessions of CO2


fractional laser (SmartXide Dot, Deka, Italy). Improvement in


the skin texture and quality, mouth commissure and nasolabial folds can be seen


June 2012 | prime-journal.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84